ArticleAmerican journal of respiratory and critical care medicine2023
Combination of BAL and Computed Tomography Differentiates Progressive and Non-progressive Fibrotic Lung Diseases.
Abstract read
In one paragraph
Article in American journal of respiratory and critical care medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 1 synthesis or guideline pooled it.
- BAL lymphocytosis as a predictive marker for drug response and long-term outcome in fibrotic ILD: systematic review.BMJ open respiratory research · 2026Pooled it
- Prognostic Value of Bronchoalveolar Lavage in Systemic Autoimmune Rheumatic Diseases-Associated Interstitial Lung Disease.Journal of clinical medicine · 2026Article
- Incremental contribution of bronchoalveolar lavage fluid data to multidisciplinary discussion of interstitial lung disease.BMC pulmonary medicine · 2026Article
- Patterns of bronchoalveolar lavage in fibrotic and non-fibrotic interstitial lung diseases - a multicenter analysis.BMC pulmonary medicine · 2026Article
- Association of bronchoalveolar lavage cellular analysis and radiological findings in fibrotic interstitial lung diseases.BMJ open respiratory research · 2026Article
- Does bronchoalveolar lavage lymphocytosis predict prognosis in fibrotic hypersensitivity pneumonitis, and is this relationship influenced by low-dose immunomodulatory therapy at the time of BAL?Frontiers in medicine · 2026Article
- Epidemiology and Prognosis of Progressive Pulmonary Fibrosis: A Literature Review.Pulmonary therapy · 2025Review
- Single-cell transcriptomic analysis of blood and bronchoalveolar lavage fluid in progressive fibrosing interstitial lung diseases.Scientific reports · 2025Article
- Analysis of the relationship between bronchoalveolar lavage lymphocyte fraction and detailed autoimmune features in patients with idiopathic interstitial pneumonia.Scientific reports · 2025Article
- Clinical Insights and Therapeutic Strategies for the Treatment of Interstitial Lung Disease in Patients with Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: Current Trends and Future Directions.Journal of clinical medicine · 2025Review
- Extent of lung fibrosis is of greater prognostic importance than HRCT pattern in patients with progressive pulmonary fibrosis: data from the ILD-PRO registry.Respiratory research · 2025Article
- BAL Fluid Cellular Analysis and Radiologic Patterns in Patients With Fibrotic Interstitial Lung Disease.Chest · 2025Article
- Predicting biomarkers of progressive pulmonary fibrosis: morphological, cytokine profile, and clinical portrait.Frontiers in immunology · 2025Article
- Identification of progressive pulmonary fibrosis: consensus findings from a modified Delphi study.Respiratory research · 2024Article
- Neutrophils and Lymphocytes: Yin and Yang of Lung Fibrosis and Patient Outcome in Diffuse Interstitial Lung Diseases.Biomedicines · 2024Article
- Corticosteroid therapy in fibrotic interstitial lung disease: a modified Delphi survey.ERJ open research · 2024Article
- The Role of Inflammation and Fibrosis in Interstitial Lung Disease Treatment Decisions.American journal of respiratory and critical care medicine · 2024Article
- The immune mechanisms of acute exacerbations of idiopathic pulmonary fibrosis.Frontiers in immunology · 2024Review
- To Progress or Not to Progress, That Is the Question! Progression in Fibrotic Interstitial Lung Disease.American journal of respiratory and critical care medicine · 2023Article
- Clinical implications of bronchoalveolar lavage fluid cellular analysis in fibrotic interstitial lung disease combined with CT quantification.Therapeutic advances in respiratory diseaseArticle
Corrections and comments
- Commented on by
Authors and funding
21 authors.
Joseph L BarnettDepartment of Radiology, Royal Free Hospital, London, United Kingdom.
Toby M MaherKeck School of Medicine, University of Southern California, Los Angeles, California.
Jennifer K QuintNational Heart and Lung Institute, Imperial College, London, United Kingdom.
Alex AdamsonNational Heart and Lung Institute, Imperial College, London, United Kingdom.
Zhe WuNational Heart and Lung Institute, Imperial College, London, United Kingdom.
David J F SmithNational Heart and Lung Institute, Imperial College, London, United Kingdom.
Bhavin RawalDepartment of Radiology.
Arjun NairDepartment of Radiology, University College Hospital, London, United Kingdom.
Simon L F WalshNational Heart and Lung Institute, Imperial College, London, United Kingdom.
Sujal R DesaiNational Heart and Lung Institute, Imperial College, London, United Kingdom.
Peter M GeorgeNational Heart and Lung Institute, Imperial College, London, United Kingdom.ORCID 0000-0003-1316-4891
Maria KokosiNational Heart and Lung Institute, Imperial College, London, United Kingdom.
Gisli JenkinsNational Heart and Lung Institute, Imperial College, London, United Kingdom.
Vasilis KouranosNational Heart and Lung Institute, Imperial College, London, United Kingdom.
Elisabetta A RenzoniNational Heart and Lung Institute, Imperial College, London, United Kingdom.
Alex RiceNational Heart and Lung Institute, Imperial College, London, United Kingdom.
Andrew G NicholsonNational Heart and Lung Institute, Imperial College, London, United Kingdom.
Felix ChuaNational Heart and Lung Institute, Imperial College, London, United Kingdom.
Athol U WellsNational Heart and Lung Institute, Imperial College, London, United Kingdom.
Philip L MolyneauxNational Heart and Lung Institute, Imperial College, London, United Kingdom.
Anand DevarajNational Heart and Lung Institute, Imperial College, London, United Kingdom.ORCID 0009-0006-5982-6810
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Idiopathic Pulmonary FibrosisLung Diseases, InterstitialDisease ProgressionHumansLungRetrospective StudiesTomographyTomography, X-Ray ComputedBALcomputed tomographylymphocytosispulmonary fibrosisusual interstitial pneumonia
Identifiers
PMID
37672028What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.